TY - JOUR
T1 - Molecular plasticity of human melanoma cells
AU - Hendrix, Mary J.C.
AU - Seftor, Elisabeth A.
AU - Hess, Angela R.
AU - Seftor, Richard E.B.
N1 - Funding Information:
We gratefully acknowledge the scientific collaborations with Drs Paul Meltzer and Jeffrey Trent (National Human Genome Research Institute), and Drs Gina Schatteman, Don Sheriff, Dawn Kirschmann, and Ms Lynn Gruman (The University of Iowa). This research was supported by NIH/National Cancer Institute Grants CA80318, CA59702 and CA88043-02S1 (to MJCH), CA83137 (to REBS) and Oncology Research Training Award from The Holden Comprehensive Cancer Center’s Institutional National Research Service Award 2 T32 CA79445-03 (to ARH).
PY - 2003/5/19
Y1 - 2003/5/19
N2 - The molecular analysis of tumors, such as melanoma, has benefited significantly from microarray technology that can facilitate the classification of tumors based on the differential expression of genes. The data summarized in this review describe the molecular profile of aggressive cutaneous and uveal melanoma cells as that of multiple phenotypes similar to a pluripotent, embryonic-like stem cell. A noteworthy example of the plasticity of the aggressive melanoma cell phenotype is demonstrated by the ability of these tumor cells to engage in vasculogenic mimicry and neovascularization. A review of the current evidence demonstrating important cellular and molecular determinants of melanoma vasculogenic mimicry is presented. In addition, novel signaling pathways are discussed, involving VE-cadherin, EphA2, FAK, and PI 3-kinase, which promote cell migration, invasion, and matrix remodeling. The observations summarized in this review describe some of the key molecular events that regulate the process of melanoma vasculogenic mimicry and identify new signal transduction pathways that can serve as putative targets for therapeutic intervention.
AB - The molecular analysis of tumors, such as melanoma, has benefited significantly from microarray technology that can facilitate the classification of tumors based on the differential expression of genes. The data summarized in this review describe the molecular profile of aggressive cutaneous and uveal melanoma cells as that of multiple phenotypes similar to a pluripotent, embryonic-like stem cell. A noteworthy example of the plasticity of the aggressive melanoma cell phenotype is demonstrated by the ability of these tumor cells to engage in vasculogenic mimicry and neovascularization. A review of the current evidence demonstrating important cellular and molecular determinants of melanoma vasculogenic mimicry is presented. In addition, novel signaling pathways are discussed, involving VE-cadherin, EphA2, FAK, and PI 3-kinase, which promote cell migration, invasion, and matrix remodeling. The observations summarized in this review describe some of the key molecular events that regulate the process of melanoma vasculogenic mimicry and identify new signal transduction pathways that can serve as putative targets for therapeutic intervention.
KW - EphA2
KW - Melanoma
KW - Plasticity
KW - VE-cadherin
KW - Vasculogenic mimicry
UR - http://www.scopus.com/inward/record.url?scp=0038457473&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038457473&partnerID=8YFLogxK
U2 - 10.1038/sj.onc.1206447
DO - 10.1038/sj.onc.1206447
M3 - Review article
C2 - 12789282
AN - SCOPUS:0038457473
SN - 0950-9232
VL - 22
SP - 3070
EP - 3075
JO - Oncogene
JF - Oncogene
IS - 20
ER -